Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bock

Showing results (11-20 of 505) with videos related to

Pageof 51
Sort By:
Critical Pathways in Cardiology|March 15, 2008
Smoking cessationBeth C Bock, Bruce Becker
European Journal of Orthodontics|June 21, 2018
Long-term (≥15 years) effects of Class II treatment: a longitudinal and cross-sectional study on signs and symptoms of temporomandibular disordersSabine Ruf, Niko C Bock
European Journal of Orthodontics|July 26, 2011
Dentoskeletal changes in adult Class II division 1 Herbst treatment--how much is left after the retention period?Niko C Bock, Sabine Ruf
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 18, 2013
Development and validation of a confirmatory method for the determination of tranquilisers and a β-blocker in porcine and bovine kidney by LC-MS/MSC Bock, C S Stachel
Nucleic Acids Research|May 11, 1991
A NheI RFLP in the human antithrombin III gene (1q23-q25) (AT3)S C Bock, E Radziejewska
The Journal of Innovations in Cardiac Rhythm Management|October 13, 2025
BrugadaphobiaLaszlo Littmann, William C Bock
Focus on Critical Care|April 1, 1991
Critical care transportC Bock-Laudenslager, L M Johnson
Annals of Emergency Medicine|April 1, 1988
Computerized mega code recordingT W Burt, H C Bock
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1999
Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidineC Bock, N Niederhoffer, B Szabo
The Journal of Urology|March 1, 1989
Protein inhibitors of crystal growthE T Kaiser, S C Bock
Pageof 51

Showing results (11-20 of 505) with videos related to

Sort By:
Pageof 51
Critical Pathways in Cardiology|March 15, 2008
Smoking cessationBeth C Bock, Bruce Becker
European Journal of Orthodontics|June 21, 2018
Long-term (≥15 years) effects of Class II treatment: a longitudinal and cross-sectional study on signs and symptoms of temporomandibular disordersSabine Ruf, Niko C Bock
European Journal of Orthodontics|July 26, 2011
Dentoskeletal changes in adult Class II division 1 Herbst treatment--how much is left after the retention period?Niko C Bock, Sabine Ruf
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 18, 2013
Development and validation of a confirmatory method for the determination of tranquilisers and a β-blocker in porcine and bovine kidney by LC-MS/MSC Bock, C S Stachel
Nucleic Acids Research|May 11, 1991
A NheI RFLP in the human antithrombin III gene (1q23-q25) (AT3)S C Bock, E Radziejewska
The Journal of Innovations in Cardiac Rhythm Management|October 13, 2025
BrugadaphobiaLaszlo Littmann, William C Bock
Focus on Critical Care|April 1, 1991
Critical care transportC Bock-Laudenslager, L M Johnson
Annals of Emergency Medicine|April 1, 1988
Computerized mega code recordingT W Burt, H C Bock
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1999
Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidineC Bock, N Niederhoffer, B Szabo
The Journal of Urology|March 1, 1989
Protein inhibitors of crystal growthE T Kaiser, S C Bock
Pageof 51